Search Results (7)

This study explored the efficacy, residue dynamics, and dietary risks of sulfoxaflor and flupyradifurone in Cudrania tricuspidata. Following two applications, residue levels of sulfoxaflor and flupyradifurone decreased from 0.254 to 0.012 mg/kg and 0.732 to 0.016 mg/kg, respectively, over a period of 22 days. The half-lives (t_1/2) in fruits and leaves ranged from 7.0 to 13.6 days. LC-MS/MS analysis showed recovery rates of 79.8–94.9% and RSD < 8.5%. Both pesticides effectively controlled hemipteran pests, reducing aphid and spotted lanternfly populations by >90%. Acute and chronic dietary risk assessments indicated acute hazard index (aHI) and chronic hazard quotient (HQ) values remarkably < 1, suggesting a negligible health risk. According to these results, sulfoxaflor and flupyradifurone have recently been registered as pesticides for C. tricuspidata against hemipteran pests, with a recommended pre-harvest interval of 7 days, as projected residue levels (0.078–5.213 mg/kg) were below established maximum residue limits (MRLs). These findings indicate a low dietary risk associated with sulfoxaflor and flupyradifurone in C. tricuspidata when applied according to the evaluated application rates and pre-harvest interval. Full article

A high-performance liquid chromatography (HPLC) method using a diode array detector (DAD) was developed and validated for the simultaneous quantification of chlorogenic acid, rutin, and isoquercitrin, which are key bioactive compounds in Cudrania tricuspidata leaves. The method demonstrated excellent specificity, precision, and accuracy in accordance with the guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Calibration curves showed outstanding linearity (r² > 0.99), with recovery rates of 101.63%, 101.81%, and 102.18% for chlorogenic acid, rutin, and isoquercitrin, respectively. The limits of detection (LOD) were 0.286, 0.411, and 0.201 μg/mL, and the limits of quantification (LOQ) were 1.246, 0.866, and 0.608 μg/mL for chlorogenic acid, rutin, and isoquercitrin, respectively. Additionally, response surface methodology (RSM) based on a Box–Behnken design was employed to optimize the extraction conditions of the three marker compounds. The second-order regression models showed high coefficients of determination (r²) and significant ANOVA results (p < 0.05). RSM analysis revealed that extraction temperature and ethanol concentration exerted the most significant effects on the extraction yields, while extraction time played a supportive role. The optimal conditions (70 °C, 40% ethanol, 120 min) significantly enhanced compound recovery while reducing solvent and energy consumption, thereby contributing to the development of efficient and sustainable extraction processes. Collectively, the validated HPLC-DAD method and the optimized extraction strategy developed in this study provide a reliable framework for the quality standardization and industrial application of C. tricuspidata leaf extracts in functional food, cosmetic, and pharmaceutical products. Full article

We investigated the antioxidant activity and neuroprotective effects of an enzymatic hydrolyzate from silkworms fed the leaves of Cudrania tricuspidata (ESLC) produced by enzymatic treatment. The proteins in silkworms fed the leaves of Cudrania tricuspidata (SLC) were effectively hydrolyzed using enzymatic treatment. The total polyphenols of ESLC were significantly higher, and the superoxide dismutase-like activity and 2,2′-azino-bis (3-thylbenzothiazoline-6-sulfonicacid) diammonium salt radical scavenging capacity of ESLC were significantly increased compared to the SLC group. We evaluated the properties of ESLC to protect SH-SY5Y cells from H₂O₂-induced oxidative stress. The viability rate of SH-SY5Y neuroblastoma cells was significantly restored when treated with ESLC at a concentration of 100 μg/mL or 250 μg/mL. Furthermore, the mitogen-activated protein kinase (MAPK) pathway was investigated, and ESLC significantly inhibited the phosphorylation of c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38. Therefore, ESLC can potentially be used as an antioxidant. The polyphenol content increases owing to hydrolysis through enzymatic treatment, which increases the antioxidant effect and inhibits the phosphorylation of JNK, ERK, and p38 by activating the MAPK pathway, which inhibits cell death from oxidative stress and exerts cytoprotective effects. Full article

This study investigated the memory-improving effects and mechanisms of action of hydrolysate from silkworm fed Cudrania tricuspidata leaves (HSCT) in rats with scopolamine-induced memory impairment. Thirty-two rats were categorized into 4 groups and the experiment was conducted for 6 weeks. The experimental diet groups are as follows: control, control diet; scopolamine, control diet + scopolamine (0.7 mg/kg); HSCT, HSCT diet + scopolamine (0.7 mg/kg); and donepezil, control diet + scopolamine (0.7 mg/kg) + donepezil (1.0 mg/kg). Except for the control group, the experimental groups received scopolamine 0.7 mg/kg intraperitoneally to induce decline in memory. Animal behavioral tests such as the Barnes maze, novel object recognition test, and Y-maze were performed to investigate the effects of HSCT on memory improvement. In addition, brain acetylcholine (ACh) concentration and acetylcholinesterase (AChE) activity were assessed to investigate the mechanism of memory improvement. Results of the animal behavior test suggested that the rats administered HSCT displayed improved memory behavior compared to those administered scopolamine (p < 0.05). The concentration of Ach was increased in the HSCT group compared to the scopolamine group (p < 0.05), and the activity of AChE was significantly reduced (p < 0.05). These results suggest that HSCT effectively improves memory by reducing AChE activity and increasing ACh content in the brains of rats with scopolamine-induced memory impairment. As a natural compound, HSCT has the potential to be used as a material to improve memory. Full article

Green-synthesized silver nanoparticles (SNPs) have great potential for biomedical applications, due to their distinctive optical, chemical, and catalytic properties. In this study, we aimed to develop green-synthesized SNPs from extracts of Cudrania tricuspidata (CT) roots (CTR), stems (CTS), leaves (CTL), and fruit (CTF) and to evaluate their physicochemical, photocatalytic, and biological properties. CTR, CTS, CTL, and CTF extracts were evaluated and compared for their total phenol and flavonoid content, reducing capacity, and antioxidant activity. The results revealed that CTR, CTS, CTL, and CTF extracts have high phenol and flavonoid content, as well as a powerful antioxidant and reducing capacity. CTR and CTS extracts showed the strongest effects. The results from UV-Vis spectra analysis, dynamic light scattering, high-resolution transmission electron microscopy, energy dispersive spectroscopy, X-ray diffraction, and Fourier-transform infrared spectroscopy showed the successful formation of CT-SNPs with surface morphology, crystallinity, reduction capacity, capsulation, and stabilization. Synthesized CT-SNPs successfully photocatalyzed methylene blue, methyl orange, rhodamine B, and Reactive Black 5 within 20 min. The CTR- and CTS-SNPs showed better antibacterial properties against different pathogenic microbes (Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Salmonella enteritidis) than the CTL- and CTF-SNPs. CTS- and CTR-SNPs showed the most effective cytotoxicity and antiapoptosis properties in human hepatocellular carcinoma cells (HepG2 and SK-Hep-1). CT-SNPs also seemed to be more biologically active than the CT extracts. The results of this study provide evidence of the establishment of CT extract SNPs and their physicochemical, photocatalytic, and biological properties. Full article

Cudrania tricuspidata Bureau (Moraceae) shows numerous pharmacological effects and has been used in traditional herbal remedies for inflammation, gastritis, tumors, and liver diseases. However, no validated analytical method for the standardization and optimization of the biological properties of C. tricuspidata preparations has been reported. We developed and validated a reverse-phase high-performance liquid chromatography (HPLC) method for the separation and quantification of active markers. Ethanolic extracts of C. tricuspidata leaves were prepared and evaluated for chemical profiles and biological activities. The 80% ethanolic extract demonstrated the greatest antioxidant activity and phenolic content, while the 100% ethanolic extract had the greatest total flavonoid content and xanthine oxidase (XO) inhibitory activity. The validated HPLC method confirmed that chlorogenic acid, rutin, and kaempferol were present in C. tricuspidata leaf extracts. We postulated that the antioxidant and anti-hyperuricemic/gout effects of C. tricuspidata extract could be attributed to these marker compounds. Our results suggested that the flavonoid-rich fraction of the leaf extract may be utilized for the treatment and prevention of hyperuricemia-related diseases, and the validated method and marker compounds could be applied for the quality control of C. tricuspidata preparations. Full article

In this study, we quantitated kaempferol in water extract from Cudrania tricuspidata leaves (CTL) and investigated its effects on endoplasmic reticulum (ER) stress-induced inflammation and insulin resistance in HepG2 cells. The concentration of kaempferol in the CTL was 5.07 ± 0.08 mg/g. The HepG2 cells were treated with 300 µg/mL of CTL, 500 µg/mL of CTL, 1.5 µg/mL of kaempferol or 2.5 µg/mL of kaempferol, followed immediately by stimulation with 100 nM of thapsigargin for ER stress induction for 24 h. There was a marked increase in the activation of the ER stress and inflammation response in the thapsigargin-stimulated control group. The CTL treatment interrupted the ER stress response and ER stress-induced inflammation. Kaempferol partially inhibited the ER stress response and inflammation. There was a significant increase in serine phosphorylation of insulin receptor substrate (IRS)-1 and the expression of C/EBPα and gluconeogenic genes in the thapsigargin-stimulated control group compared to the normal control. Both CTL and kaempferol suppressed serine phosphorylation of IRS-1, and the treatments did not interrupt the C/EBPα/gluconeogenic gene pathway. These results suggest that kaempferol might be the active compound of CTL and that it might protect against ER stress-induced inflammation and hyperglycemia. Full article